TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF)(“Maricann”
or the “Company) is pleased to announce that the Company has been selected by The Ontario Cannabis Store (“OCS”) to supply a
variety of safe, high quality cannabis products through its online store launching October 17, 2018.
Maricann will supply 37 listings with a wide range of sizes, formats and strains. The Company is committed to
supporting the Ontario economy, with state-of-the-art low cost, high efficiency facilities based in Langton, Ontario. Maricann has
invested over $100MM into south western Ontario with near term plans for further expansion.
Today’s announcement marks Maricann’s fourth provincial supply contract, cementing its position as a bona fide
national player in Canada’s recreational cannabis market. Maricann proudly looks forward to serving Ontarians through the OCS
ecommerce platform on October 17, 2018, and in the near future with private retailers.
“This is an exciting milestone for our team and positions us for success in the coming months as we ready to
launch our unique strains and technology in Canada,” says Ben Ward, CEO, Maricann Group Inc. “We’re proud to call Ontario home with
our world class purpose built facility in Langton, Ontario, and we look forward to creating more growth and opportunity now with
the OCS.”
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was
founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario
where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from
the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.
Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada to 942,000 sq. ft. (87,515 sq.
m) and will continue to pursue new opportunities in Europe.
Forward Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited
to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other
plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are
subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results,
performance, or achievements of the Company to be materially different from future events, results, performance, and achievements
expressed or implied by forward-looking information and statements herein. Such statements include those relating to future
expansion. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the
use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no
assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised
to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking
information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as
required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking
information and statements herein or to update the reasons that actual events or results could or do differ from those projected in
any forward looking information and statements herein, whether as a result of new information, future events or results, or
otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news
release.
For more information about Maricann, please visit our website at www.maricann.com
CONTACT INFORMATION
Investor Relations
Graham Farrell
Director of Investor Relations
graham@maricann.com
647-643-7665
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland
